Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata
Clinical trial NCT05368103 · COMPLETED
Trial details
- NCT number
- NCT05368103
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-27
- Primary completion
- 2023-08-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.